G9a Inhibition by CM-272: Developing a Novel Anti-Tumoral Strategy for Castration-Resistant Prostate Cancer Using 2D and 3D In Vitro Models

Investigators concluded that inhibition of G9a methyltransferase activity by CM-272 has anti-tumor effect in prostate cancer cells, holding therapeutic potential against CRPC.